{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:52:21Z","timestamp":1788245541389,"version":"build-2803163510"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n<jats:title>Background and Aims::<\/jats:title>\n<jats:p> Due to the lack of an effective vaccine and complexity of the control\nmeasures against vectors and reservoir hosts, the control of leishmaniasis depends primarily on\nchemotherapy. This study was aimed to assess the snake venom, Naja naja oxiana fraction 11(NNOVF11)\non Leishmania infantum and its broad mode of action.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods::<\/jats:title>\n<jats:p>A wide range of in vitro advanced assays including high-performance liquid chromatography\n(HPLC), MTT (3-[4, 5-Dimethylthiazol-2-yl]-2, 5diphenyltetrazolium bromide; Thiazolyl blue),\nmacrophage assays, quantitative real-time polymerase chain reaction (qPCR), flow cytometry and enzyme-\nlinked immunosorbent assay (ELISA) on L. infantum promastigote and amastigote stages were\nused. IC<jats:sub>50<\/jats:sub> values of L. infantum stages, CC<jats:sub>50<\/jats:sub> value, and apoptosis were also analyzed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results::<\/jats:title>\n<jats:p>The NNOV-F11 demonstrated strong antileishmanial activity against L. infantum stages in a\ndose-dependent manner compared to the untreated control group. Interleukin (IL)-12, TNF-\u03b1, and\niNOS genes expression as the indicators of T helper(h)1 response significantly increased; in contrast,\nthe expression level of IL-10, as the representative of Th2 response significantly decreased (p &lt; 0.001).\nReactive oxygen species (ROS) detection showed a significant increase (p &lt; 0.001) after treatment\nwith different concentrations of NNOV-F11, unlike arginase (ARG) activity, which displayed a significant\nreduction (p &lt; 0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p>NNOV-F11 possessed a potent inhibitory effect on L. infantum stages with the multifunctional\nand broad mode of actions, which promoted the immunomodulatory role, induced ROS production,\nstimulated apoptotic\u2013like mechanisms, and inhibited L-ARG activity, which collectively led to\nthe parasite death. Further studies are crucial to assess the effect of the NNOV-F11 on animal models\nor clinical settings.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530320999201110211222","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T05:18:46Z","timestamp":1605158326000},"page":"1115-1124","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Fraction of the Snake Venom, Its Leishmanicidal Effect, and the Stimulation of an Anti-Leishmania Response in Infected Macrophages"],"prefix":"10.2174","volume":"21","author":[{"given":"Saeideh","family":"Nikpour","sequence":"first","affiliation":[{"name":"Department of Parasitology and Mycology, Faculty of Medicine, Iran University of Medical Sciences, Tehran,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tabatabaie","sequence":"additional","affiliation":[{"name":"Department of Parasitology and Mycology, Faculty of Medicine, Iran University of Medical Sciences, Tehran,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[{"name":"Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Mostafavi","sequence":"additional","affiliation":[{"name":"Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh T.","family":"Oliaee","sequence":"additional","affiliation":[{"name":"Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sharifi","sequence":"additional","affiliation":[{"name":"Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Babaei","sequence":"additional","affiliation":[{"name":"Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Jafari","sequence":"additional","affiliation":[{"name":"Pathology and Stem Cell Research Center, Kerman University of Medical Science, Kerman,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Salarkia","sequence":"additional","affiliation":[{"name":"Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delavar","family":"Shahbazzadeh","sequence":"additional","affiliation":[{"name":"Laboratory of Venom and Biotherapeutics Molecules, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"Scott D.A.","year":"2016","unstructured":"Scott D.A.; Slaymaker I.M.; Gao L.; Zetsche B.; Yan W.X.; Zhang F.; Rationally engineered Cas9 nucleases with improved specificity. Science 2016,351(6268),84-88","journal-title":"Science"},{"key":"ref=2","first-page":"544","volume":"12","author":"Khosravi A.","year":"2017","unstructured":"Khosravi A.; Sharifi I.; Fekri A.; Kermanizadeh A.; Bamorovat M.; Mostafavi M.; Aflatoonian M.R.; Keyhani A.; Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, southeastern Iran, 1994-2014. Iran J Parasitol 2017,12(4),544-553","journal-title":"Iran J Parasitol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.pt.2019.06.007","volume":"35","author":"Le Rutte E.A.","year":"2019","unstructured":"Le Rutte E.A.; Zijlstra E.E.; de Vlas S.J.; Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission. Trends Parasitol 2019,35(8),590-592","journal-title":"Trends Parasitol"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005739","volume":"11","author":"Bailey F.","year":"2017","unstructured":"Bailey F.; Mondragon-Shem K.; Hotez P.; Ruiz-Postigo J.A.; Al-Salem W.; Acosta-Serrano \u00c1.; Molyneux D.H.; A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates. PLoS Negl Trop Dis 2017,11(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4269\/ajtmh.16-0151","volume":"95","author":"Akter S.","year":"2016","unstructured":"Akter S.; Alam M.Z.; Nakao R.; Yasin G.; Kato H.; Katakura K.; Molecular and Serological Evidence of Leishmania Infection in Stray Dogs from Visceral Leishmaniasis-Endemic Areas of Bangladesh. Am J Trop Med Hyg 2016,95(4),795-799","journal-title":"Am J Trop Med Hyg"},{"key":"ref=6","year":"(2010)","unstructured":"Committee on the control of the Leishmaniases  WHO ExpertControl of the leishmaniases: report of a meeting of the WHO Expert Commitee on the control of Leishmaniases, Geneva, 22-26 March 2010. World Health Organization. Available at:\n(2010)","journal-title":"Committee on the control of the Leishmaniases"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007423","volume":"13","author":"Aflatoonian M.R.","year":"2019","unstructured":"Aflatoonian M.R.; Sharifi I.; Aflatoonian B.; Bamorovat M.; Heshmatkhah A.; Babaei Z.; Almani P.G.N.; Mohammadi M.A.; Salarkia E.; Aghaei Afshar A.; Sharifi H.; Sharifi F.; Khosravi A.; Khatami M.; Arefinia N.; Fekri A.; Farajzadeh S.; Khamesipour A.; Mohebali M.; Gouya M.M.; Shirzadi M.R.; Varma R.S.; Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran. PLoS Negl Trop Dis 2019,13(6)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/tmi.13062","volume":"23","author":"Oliaee R.T.","year":"2018","unstructured":"Oliaee R.T.; Sharifi I.; Afgar A.; Kareshk A.T.; Asadi A.; Heshmatkhah A.; Bamorovat M.; Jafarzadeh A.; Mohammadi M.A.; Daneshvar H.; Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling. Trop Med Int Health 2018,23(6),622-633","journal-title":"Trop Med Int Health"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1093\/cid\/ciw670","volume":"63","author":"Aronson N.","year":"2016","unstructured":"Aronson N.; Herwaldt B.L.; Libman M.; Pearson R.; Lopez-Velez R.; Weina P.; Carvalho E.M.; Ephros M.; Jeronimo S.; Magill A.; Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 2016,63(12),e202-e264","journal-title":"Clin Infect Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/DDDT.S146521","volume":"12","author":"Ghorbani M.","year":"2017","unstructured":"Ghorbani M.; Farhoudi R.; Leishmaniasis in humans: drug or vaccine therapy? Drug Des Devel Ther 2017,12,25-40","journal-title":"Drug Des Devel Ther"},{"key":"ref=11","first-page":"13","volume":"138","author":"Nasoori A.","year":"2016","unstructured":"Nasoori A.; Shahbazzadeh D.; Tsubota T.; Young B.; The defensive behaviour of Naja oxiana, with comments on the visual displays of cobras. Herpetol Bull 2016,138,13-17","journal-title":"Herpetol Bull"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/B978-008045382-8.00114-3","volume":"Vol. 5","author":"Andreotti N.","year":"2010","unstructured":"Andreotti N.; Jouirou B.; Mouhat S.; Mouhat L.; Sabatier J-M.; Therapeutic value of peptides from animal venoms. Comprehensive natural products II; Hung-Wen (Ben) Liu, Lew Mander 2010,Vol. 5,287-303","journal-title":"Comprehensive natural products II; Hung-Wen (Ben) Liu, Lew Mander"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.exppara.2013.06.006","volume":"135","author":"Bhattacharya S.","year":"2013","unstructured":"Bhattacharya S.; Ghosh P.; De T.; Gomes A.; Gomes A.; Dungdung S.R.; In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity. Exp Parasitol 2013,135(1),126-133","journal-title":"Exp Parasitol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.toxicon.2009.11.013","volume":"55","author":"Costa Torres A.F.","year":"2010","unstructured":"Costa Torres A.F.; Dantas R.T.; Toyama M.H.; Diz Filho E.; Zara F.J.; Rodrigues de Queiroz M.G.; Pinto Nogueira N.A.; Rosa de Oliveira M.; de Oliveira Toyama D.; Monteiro H.S.A.; Martins A.M.C.; Antibacterial and antiparasitic effects of Bothrops marajoensis venom and its fractions: Phospholipase A2 and L-amino acid oxidase. Toxicon 2010,55(4),795-804","journal-title":"Toxicon"},{"key":"ref=15","author":"Altgelt K.H.","year":"1993","unstructured":"Altgelt K.H.;  Composition and analysis of heavy petroleum fractions 1993","journal-title":"Composition and analysis of heavy petroleum fractions"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3791\/1610","author":"Desjardins P.","year":"2010","unstructured":"Desjardins P.; Hansen J.B.; Allen M.; Microvolume protein concentration determination using the NanoDrop 2000c Spectrophotometer. J Vis Exp 2010(33),1610","journal-title":"J Vis Exp"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00436-011-2599-6","volume":"110","author":"Shokri A.","year":"2012","unstructured":"Shokri A.; Sharifi I.; Khamesipour A.; Nakhaee N.; Fasihi Harandi M.; Nosratabadi J.; Hakimi Parizi M.; Barati M.; The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate. Parasitol Res 2012,110(3),1113-1117","journal-title":"Parasitol Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mimet.2005.10.011","volume":"66","author":"Ganguly S.","year":"2006","unstructured":"Ganguly S.; Bandyopadhyay S.; Sarkar A.; Chatterjee M.; Development of a semi-automated colorimetric assay for screening anti-leishmanial agents. J Microbiol Methods 2006,66(1),79-86","journal-title":"J Microbiol Methods"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"Croft S.L.","year":"2006","unstructured":"Croft S.L.; Sundar S.; Fairlamb A.H.; Drug resistance in leishmaniasis. Clin Microbiol Rev 2006,19(1),111-126","journal-title":"Clin Microbiol Rev"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034022","volume":"7","author":"da Silva M.F.L.","year":"2012","unstructured":"da Silva M.F.L.; Zampieri R.A.; Muxel S.M.; Beverley S.M.; Floeter-Winter L.M.; Leishmania amazonensis arginase compartmentalization in the glycosome is important for parasite infectivity. PLoS One 2012,7(3)","journal-title":"PLoS One"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/cmr.19.1.111-126.2006","volume":"19","author":"Croft S.L.","year":"2006","unstructured":"Croft S.L.; Sundar S.; Fairlamb A.H.; Drug Resistance in Leishmaniasis Drug Resistance in Leishmaniasis. Clin Microbiol Rev 2006,19(1),111-126","journal-title":"Clin Microbiol Rev"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/695382","volume":"2011","author":"Jeddi F.","year":"2011","unstructured":"Jeddi F.; Piarroux R.; Mary C.; Antimony resistance in leishmania, focusing on experimental research. J Trop Med 2011,2011","journal-title":"J Trop Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","volume":"7","author":"Ouellette M.","year":"2004","unstructured":"Ouellette M.; Drummelsmith J.; Papadopoulou B.; Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updat 2004,7(4-5),257-266","journal-title":"Drug Resist Updat"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.exppara.2013.07.018","volume":"135","author":"Kazemi-Rad E.","year":"2013","unstructured":"Kazemi-Rad E.; Mohebali M.; Khadem-Erfan M.B.; Saffari M.; Raoofian R.; Hajjaran H.; Hadighi R.; Khamesipour A.; Rezaie S.; Abedkhojasteh H.; Heidari M.; Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Exp Parasitol 2013,135(2),344-349","journal-title":"Exp Parasitol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2019.03.005","volume":"195","author":"Costa M.S.","year":"2019","unstructured":"Costa M.S.; Gon\u00e7alves Y.G.; Teixeira S.C.; Nunes D.C.O.; Lopes D.S.; da Silva C.V.; da Silva M.S.; Borges B.C.; Silva M.J.B.; Rodrigues R.S.; Rodrigues V.M.; Von Poelhsitz G.; Yoneyama K.A.G.; Increased ROS generation causes apoptosis-like death: Mechanistic insights into the anti-Leishmania activity of a potent ruthenium(II) complex. J Inorg Biochem 2019,195,1-12","journal-title":"J Inorg Biochem"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2019.152248","volume":"425","author":"Yang B.","year":"2019","unstructured":"Yang B.; Yin C.; Zhou Y.; Wang Q.; Jiang Y.; Bai Y.; Qian H.; Xing G.; Wang S.; Li F.; Feng Y.; Zhang Y.; Cai J.; Aschner M.; Lu R.; Curcumin protects against methylmercury-induced cytotoxicity in primary rat astrocytes by activating the Nrf2\/ARE pathway independently of PKC\u03b4. Toxicology 2019,425","journal-title":"Toxicology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29245\/2689-9981\/2018\/3.1120","volume":"1","author":"Jawed J.J.","year":"2018","unstructured":"Jawed J.J.; Majumdar S.; Recent Trends in Leishmania Research: A Therapeutic Perspective. J Infect 2018,1,1-4","journal-title":"J Infect"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2174\/1871526520666200106121839","volume":"20","author":"Fallahi N.","year":"2020","unstructured":"Fallahi N.; Shahbazzadeh D.; Maleki F.; Aghdasi M.; Tabatabaie F.; Khanaliha K.; The in vitro study of anti-leishmanial effect of Naja naja oxiana snake venom on Leishmania major. Infect Disord Drug Targets 2020,20(6),913-919","journal-title":"Infect Disord Drug Targets"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.4049\/jimmunol.1502678","volume":"196","author":"Schaut R.G.","year":"2016","unstructured":"Schaut R.G.; Lamb I.M.; Toepp A.J.; Scott B.; Mendes-Aguiar C.O.; Coutinho J.F.V.; Jeronimo S.M.B.; Wilson M.E.; Harty J.T.; Waldschmidt T.J.; Petersen C.A.; Regulatory IgDhi B cells suppress T cell function via IL-10 and PD-L1 during progressive visceral leishmaniasis. J Immunol 2016,196(10),4100-4109","journal-title":"J Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","volume":"10","author":"Dayakar A.","year":"2019","unstructured":"Dayakar A.; Chandrasekaran S.; Kuchipudi S.V.; Kalangi S.K.; Cytokines: Key determinants of resistance or disease progression in visceral leishmaniasis: Opportunities for novel diagnostics and immunotherapy. Front Immunol 2019,10,670","journal-title":"Front Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3389\/fimmu.2018.02529","volume":"9","author":"Tomiotto-Pellissier F.","year":"2018","unstructured":"Tomiotto-Pellissier F.; Bortoleti B.T.D.S.; Assolini J.P.; Gon\u00e7alves M.D.; Carloto A.C.M.; Miranda-Sapla M.M.; Conchon-Costa I.; Bordignon J.; Pavanelli W.R.; Macrophage Polarization in Leishmaniasis: Broadening Horizons. Front Immunol 2018,9,2529","journal-title":"Front Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3389\/fmicb.2017.02682","volume":"8","author":"Muxel S.M.","year":"2018","unstructured":"Muxel S.M.; Aoki J.I.; Fernandes J.C.R.; Laranjeira-Silva M.F.; Zampieri R.A.; Acu\u00f1a S.M.; M\u00fcller K.E.; Vanderlinde R.H.; Floeter-Winter L.M.; Arginine and polyamines fate in Leishmania infection. Front Microbiol 2018,8,2682","journal-title":"Front Microbiol"},{"key":"ref=33","first-page":"107","author":"Aoki J.I.","year":"2018","unstructured":"Aoki J.I.; Muxel S.M.; Fernandes J.C.R.; Floeter-Winter L.M.; Polyamine Pathway as a Potential Target for Leishmaniases Chemotherapy. Leishmaniases as Re-Emerging Diseases 2018,107","journal-title":"Leishmaniases as Re-Emerging Diseases"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"E801","DOI":"10.1073\/pnas.1619265114","volume":"114","author":"Mandell M.A.","year":"2017","unstructured":"Mandell M.A.; Beverley S.M.; Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts. Proc Natl Acad Sci USA 2017,114(5),E801-E810","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005774","volume":"11","author":"Badirzadeh A.","year":"2017","unstructured":"Badirzadeh A.; Taheri T.; Taslimi Y.; Abdossamadi Z.; Heidari-Kharaji M.; Gholami E.; Sedaghat B.; Niyyati M.; Rafati S.; Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites. PLoS Negl Trop Dis 2017,11(7)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148084","volume":"11","author":"Carneiro P.P.","year":"2016","unstructured":"Carneiro P.P.; Concei\u00e7\u00e3o J.; Macedo M.; Magalh\u00e3es V.; Carvalho E.M.; Bacellar O.; The role of nitric oxide and reactive oxygen species in the killing of Leishmania braziliensis by monocytes from patients with cutaneous leishmaniasis. PLoS One 2016,11(2)","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.pt.2015.08.001","volume":"31","author":"Olekhnovitch R.","year":"2015","unstructured":"Olekhnovitch R.; Bousso P.; Induction, propagation, and activity of host nitric oxide: lessons from Leishmania infection. Trends Parasitol 2015,31(12),653-664","journal-title":"Trends Parasitol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1242\/jcs.114.13.2461","volume":"114","author":"Das M.","year":"2001","unstructured":"Das M.; Mukherjee S.B.; Shaha C.; Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes. J Cell Sci 2001,114(Pt 13),2461-2469","journal-title":"J Cell Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/jac\/dks498","volume":"68","author":"Ribeiro G.A.","year":"2013","unstructured":"Ribeiro G.A.; Cunha-J\u00fanior E.F.; Pinheiro R.O.; da-Silva S.A.G.; Canto-Cavalheiro M.M.; da Silva A.J.M.; Costa P.R.R.; Netto C.D.; Melo R.C.N.; Almeida-Amaral E.E.; Torres-Santos E.C.; LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis. J Antimicrob Chemother 2013,68(4),789-799","journal-title":"J Antimicrob Chemother"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014666","volume":"6","author":"Fonseca-Silva F.","year":"2011","unstructured":"Fonseca-Silva F.; Inacio J.D.F.; Canto-Cavalheiro M.M.; Almeida-Amaral E.E.; Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis. PLoS One 2011,6(2)","journal-title":"PLoS One"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/14728222.2018.1472241","volume":"22","author":"Sundar S.","year":"2018","unstructured":"Sundar S.; Singh B.; Emerging therapeutic targets for treatment of leishmaniasis. Expert Opin Ther Targets 2018,22(6),467-486","journal-title":"Expert Opin Ther Targets"},{"key":"ref=42","author":"Adak S.","year":"2015","unstructured":"Adak S.;  Leishmania 2015","journal-title":"Leishmania"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530320999201110211222","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187820\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530320999201110211222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T06:05:27Z","timestamp":1657173927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187820\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530320999201110211222","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}